3 ASX Penny Stocks With Market Caps Under A$80M

Over the last 7 days, the Australian market has remained flat, while it is down 5.4% over the past year, with earnings forecast to grow by 11% annually. For investors looking beyond established giants, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities despite being a somewhat outdated term. These stocks can provide growth potential at lower price points when supported by strong balance sheets and solid fundamentals.

Let's dive into some prime choices out of the screener.

Diatreme Resources (ASX:DRX)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Diatreme Resources Limited, along with its subsidiaries, focuses on the exploration and development of mineral properties in Australia and has a market capitalization of A$70.12 million.

Operations: The company's revenue segment consists of exploration activities for heavy mineral sands, copper, gold, and base metals in Australia, with reported revenue of -A$0.45 million.

Market Cap: A$70.12M

Diatreme Resources Limited, with a market capitalization of A$70.12 million, remains pre-revenue and unprofitable, reporting a net loss of A$3.02 million for the half year ended June 30, 2026. Despite its financial challenges, the company maintains more cash than total debt and has reduced its debt-to-equity ratio significantly over five years. However, it faces high share price volatility and negative return on equity at -3.41%. While short-term assets exceed liabilities, operating cash flow is negative, indicating potential liquidity concerns in covering debts without revenue growth or improved profitability.

• Unlock comprehensive insights into our analysis of Diatreme Resources stock in this financial health report.
• Understand Diatreme Resources' track record by examining our performance history report.

Pancontinental Energy (ASX:PCL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Pancontinental Energy NL is involved in the exploration of oil and gas properties mainly in Namibia and Australia, with a market cap of A$62.15 million.

Operations: Pancontinental Energy NL currently does not report any revenue segments.

Market Cap: A$62.15M

Pancontinental Energy NL, with a market cap of A$62.15 million, is pre-revenue and reported a net loss of A$1.43 million for the year ending June 30, 2026. The company has no debt and sufficient cash runway for over a year but faces doubts about its ability to continue as a going concern from its auditor. Its share price remains highly volatile, and it has experienced increasing losses over the past five years at an annual rate of 12.7%. Despite having no long-term liabilities and seasoned board members, profitability challenges persist without significant revenue streams.

• Click here and access our complete financial health analysis report to understand the dynamics of Pancontinental Energy.
• Gain insights into Pancontinental Energy's historical outcomes by reviewing our past performance report.

Powerhouse Ventures (ASX:PVL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Powerhouse Ventures Limited is a venture capital firm focusing on seed/startup, early venture, and incubation in growth capital companies with a market cap of A$20.98 million.

Operations: Powerhouse Ventures generates its revenue from three main segments: Advisory services (A$4.69 million), Investing activities (A$1.41 million), and Funds management (A$0.59 million).

Market Cap: A$20.98M

Powerhouse Ventures Limited, with a market cap of A$20.98 million, operates in venture capital focusing on early-stage companies. It recently launched Powerhouse Venture Partners to expand its client-facing operations, aiming to enhance value for emerging technology firms. Despite being debt-free and having short-term assets exceeding liabilities, the company's management and board lack extensive experience with average tenures under three years. Although it reported revenue of A$6.69 million for the year ending June 2026, net income declined from A$1.82 million to A$1.25 million year-on-year, reflecting challenges in maintaining profit margins amidst expansion efforts.

• Jump into the full analysis health report here for a deeper understanding of Powerhouse Ventures.
• Evaluate Powerhouse Ventures' historical performance by accessing our past performance report.

Where To Now?

• Explore the 410 names from our ASX Penny Stocks screener here.
• Seeking Other Investments? The end of cancer? These 37 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com